By Lillie D. Shockney, Gary R. Shapiro
The single textual content on hand to supply either the doctor's and patient's perspectives, this booklet offers authoritative, sensible solutions on your questions. Written through Lillie Shockney, Administrative Director of the Johns Hopkins Avon beginning Breast middle, teacher within the division of surgical procedure at Johns Hopkins collage s institution of drugs, and tireless breast melanoma sufferer recommend, with statement from actual sufferers, this publication is a useful source for an individual being affected by the scientific, mental, or emotional turmoil of this condition. Read more...
Read Online or Download 100 questions & answers about advanced and metastatic breast cancer PDF
Similar cancer books
One of many major motives of failure within the therapy of breast melanoma is the intrinsic presence of, or improvement of, drug resistance by way of the melanoma cells. contemporary reports at the mechanisms of melanoma drug resistance have yielded very important details highlighting either how tumour cells may perhaps get away those healing constraints and that drug resistance may well additional impinge on tumour mobilephone capabilities which could eventually advertise an antagonistic phone phenotype.
Omics is an rising and interesting region within the box of technology and medication. a number of promising advancements were elucidated utilizing omics (including genomics, transcriptomics, epigenomics, proteomics, metabolomics, interactomics, cytomics and bioinformatics) in melanoma learn. the improvement of high-throughput applied sciences that allow the answer of decoding melanoma from greater dimensionality will offer a data base which adjustments the face of melanoma realizing and therapeutics.
I want to thank all my co-workers who've collaborated with me, from 1963 beforehand, in organic and medical study within the box of melanoma energetic immunotherapy, of its immuno prevention and immunorestoration. they're going to usually be quoted during this publication. i'm fairly thankful to those that have helped me to write down it through reviewing a few chapters: D.
Additional info for 100 questions & answers about advanced and metastatic breast cancer
Breast cancers may keep the same hormonal receptor profile forever. However, from time to time, hormone Â�receptor–positive cancers become negative. It is unusual for a hormone receptor–negative cancer to change to hormone receptor–positive. If your doctor suspects that the hormone receptor status of your cancer may have changed, she may want to biopsy one of the metastatic spots and send it to a laboratory for estrogen and progesterone receptor tests. If your cancer is not estrogen receptor–positive or progesterone receptor–positive or both, chemotherapy is your only option.
When it is time to see how well your cancer is responding to the chemotherapy, your oncologist will have you get the necessary scans and blood work a few days before your visit. He will review these with you at your visit and discuss future chemotherapy plans with you. indb 43 8/20/08 12:32:29 PM 1 0 0 Q & A A bout A dvanced and M etastatic B reast C ancer 40. Since the chemotherapy affects my immune system, is it still okay for me to work while taking it? Are there any precautions I should use in the work place or in other social settings?
Sometimes the oncology nurse uses a syringe to push the chemotherapy through the tubing. Chemotherapy can also be infused into your veins through a vascular access device (VAD). The intramuscular (im) method involves getting an injection directly into the muscle. There is a slight pinch as the nurse places the needle into the muscle of the arm, thigh, or buttocks; however, the procedure lasts only a few seconds. This route is usually not used to give breast cancer chemotherapy, but it is used occasionally to give hormonal therapy.